Affimed NV (NASDAQ:AFMD)

5.18
BATS BZX Real-Time Price
As of 2:38pm ET
 +0.25 / +5.07%
Today’s Change
1.42
Today|||52-Week Range
5.18
+89.05%
Year-to-Date
Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript
Nov 10 / MotleyFool.com - Paid Partner Content
Affimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue Estimates
Nov 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.93
Today’s open4.98
Day’s range4.86 - 5.18
Volume27,672
Average volume (3 months)1,014,022
Market cap$435.4M
Data as of 2:38pm ET, 11/23/2020

Growth & Valuation

Earnings growth (last year)-48.51%
Earnings growth (this year)+39.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-14.50%
P/E ratioNM
Price/Sales7.35
Price/Book8.66

Competitors

----
ORTXOrchard Therapeutics...-0.05-1.11%
PBYIPuma Biotechnology I...+0.41+3.67%
CRNXCrinetics Pharmaceut...-0.60-4.38%
Data as of 2:47pm ET, 11/23/2020

Financials

Next reporting dateMarch 31, 2021
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$23.9M
Annual profit (last year)-$36.2M
Net profit margin-151.30%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Heidelberg, Baden Wuerttemberg

Forecasts